WestEnd Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50.3M Buy
74,543
+3,759
+5% +$2.23M 1.11% 22
2026
Q2
$35.5M Sell
70,784
-11,830
-14% -$5.68M 0.79% 29
2026
Q1
$40.6M Sell
82,614
-5,032
-6% -$2.73M 0.98% 24
2025
Q4
$50.8M Sell
87,646
-547
-0.6% -$309K 1.18% 24
2025
Q3
$42.8M Buy
88,193
+2,701
+3% +$1.26M 1% 30
2025
Q2
$34.7M Buy
85,492
+18,950
+28% +$7.92M 0.86% 33
2025
Q1
$33.1M Buy
66,542
+3,952
+6% +$2.14M 0.88% 33
2024
Q4
$32.6M Sell
62,590
-7,520
-11% -$4.13M 0.83% 32
2024
Q3
$43.4M Sell
70,110
-143
-0.2% -$84.6K 1.06% 27
2024
Q2
$38.8M Buy
70,253
+7,468
+12% +$4.28M 1% 28
2024
Q1
$36.5M Buy
62,785
+8,745
+16% +$4.91M 0.95% 26
2023
Q4
$28.7M Sell
54,040
-9,700
-15% -$4.7M 0.79% 33
2023
Q3
$32.3M Buy
63,740
+5,111
+9% +$2.72M 0.97% 30
2023
Q2
$30.6M Buy
+58,629
New +$31.6M 0.9% 31
2023
Q1
– Sell
-58,834
Closed -$33.2M – 21
2022
Q4
$32.4M Sell
58,834
-3,950
-6% -$2.09M 1.06% 24
2022
Q3
$31.8M Sell
62,784
-3,517
-5% -$1.97M 1.07% 26
2022
Q2
$36M Buy
+66,301
New +$36.5M 1.14% 25
2022
Q1
– Sell
-3
Closed -$1.72K – 76
2021
Q4
$2K Buy
+3
New +$1.87K ﹤0.01% 78
2021
Q3
– Hold
0
– – – 72
2021
Q2
– Hold
0
– – – 81

Other funds holding TMO

WestEnd Advisors's TMO Position: Q3 2026 in Review

WestEnd Advisors increased its Thermo Fisher Scientific (TMO) stake by 5.3% in Q3 2026, buying an estimated $2.23M and bringing the position to 74,543 shares worth $50.3M. The position accounts for 1.11% of the portfolio, ranked #22.

WestEnd Advisors first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $50.8M in Q4 2025. 2,801 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • WestEnd Advisors held 74,543 shares of Thermo Fisher Scientific worth $50.3M as of Q3 2026.
  • WestEnd Advisors bought 3,759 Thermo Fisher Scientific shares in Q3 2026, an estimated $2.23M.
  • Thermo Fisher Scientific made up 1.11% of WestEnd Advisors's portfolio in Q3 2026, its #22 holding.
  • WestEnd Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
  • WestEnd Advisors's Thermo Fisher Scientific position peaked at $50.8M in Q4 2025.
  • 2,801 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on WestEnd Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.